Advanced Proteome Therapeutics (TSXV:APC.H) Beta : 2.06 (As of May. 12, 2024)

Advanced Proteome Therapeutics Beta Chart

Advanced Proteome Therapeutics Annual Data
	Trend	Jul13	Jul14	Jul15	Jul16	Jul17	Jul18	Jul19	Jul20	Jul21	Jul22
Beta		Get a 7-Day Free Trial					1.00	-0.08	0.66	0.81	1.26

Advanced Proteome Therapeutics Quarterly Data
	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23
Beta	Get a 7-Day Free Trial															1.08	1.26	1.36	1.54	1.71

Competitive Comparison of Advanced Proteome Therapeutics's Beta

For the Biotechnology subindustry, Advanced Proteome Therapeutics's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Proteome Therapeutics's Beta Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Proteome Therapeutics's Beta distribution charts can be found below:

* The bar in red indicates where Advanced Proteome Therapeutics's Beta falls into.

Advanced Proteome Therapeutics Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Advanced Proteome Therapeutics  (TSXV:APC.H) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Advanced Proteome Therapeutics Beta Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Proteome Therapeutics (TSXV:APC.H) Business Description